drugset / Trial / NCT03694821

Knee Injection RCT

NCT03694821

RandomizedParallel-groupDouble-blindTreatment

Summary

Hypothesis: Ketorolac injection is a cost-effective adjunct in the nonoperative treatment of knee osteoarthritis (OA) compared to steroids and viscosupplementation. Aims/objectives: The objective of this randomized, controlled, double-blinded, prospective study is to assess the efficacy and cost-effectiveness of knee injection with ketorolac in the nonsurgical management of symptomatic OA compared to injections with corticosteroids and viscosupplements.

Timeline

Start
2018-07-05
Primary completion
2019-07-16
Completion
2019-07-16

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hylan G-F 20 Other / unclassified Other
Subject Ketorolac Other / unclassified 30 mg Other
Comparator Methylprednisolone Other / unclassified 80 mg Other

Indications